To learn more about the benefits of an expanded CF screen, read “Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.” by PR Sosnay, et al.
Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units
Whole-genome sequencing can potentially broaden and foreshorten differential diagnosis, resulting in fewer empirical treatments and faster progression to genetic and prognostic counseling.
Discover the NextSeq 550–flexible sequencing and array power
Learn how the NextSeq 550 is enhancing research in reproductive and genetic health and why it’s being rapidly adopted in genetic testing labs. Get a glimpse into the advantages of this integrated, cost-effective solution for diverse applications.
Utilizing NIPT in a maternal-fetal medicine practice: Dr. Martin Chavez
Continuing Medical Education (CME)
"Illumina is committed to supporting independent medical education for women's healthcare providers. Click above to participate in a free CME activity about ""The Role of Noninvasive Prenatal Screening in Optimizing Fetal Outcomes"". "
Clinical laboratory experience with noninvasive prenatal testing in twin gestations
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Prenatal testing with the use of cfDNA has significantly lower false positive rates and higher positive predictive values for detection of trisomies 21 and 18 than standard screening.
Preimplantation genetic diagnosis can be used where there is a risk of severe genetic disorders being inherited from parents. Join Professor Alan Handyside and Alan Thornhill as they introduce the Illumina karyomapping solution.
Innovative BlueFuse Multi Software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. The seamless, scalable software solution helps simplify embryo screening and streamline the clinician’s workflow.
Learn about the 2011-2012 Society for Assisted Reproductive Technology (SART) data analysis of pregnancy outcomes in IVF cycles with and without PGS as reported to the Centers for Disease Control (CDC).
Illumina is committed to supporting independent medical education for women’s health care providers. Click above to participate in a free CME activity about “Improving Fetal Outcomes Through the Use of PGD/PGS."
Simon Fishel describes how the highly-accurate VeriSeq PGS Kit empowers clinicians with accurate chromosomal insights into the health of the embryo to optimize IVF success.
Simon Fishel describes how preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) enable selection of embryos free of chromosomal problems for transfer.
Array CGH Improves Pregnancy Rate for IVF Patients
Yang et al reported a 65% increase in pregnancy at 20 weeks, with a 69.1% pregnancy rate after 24sure selection of euploid embryos (n = 55) versus 41.7% after standard morphological selection of embryos (n = 48).
A Rational Approach to IVF according to published literature
Dr. Jamie Grifo explains how PGS can be used to deliver fast, accurate information that can guide choices and change patients’ lives and reproductive futures.
Next-generation Sequencing's Potential Benefits for PGS
Simon Fishel Discusses Chromosome Screening
Simon Fishel, Managing Director of CARE Fertility, describes a clinical trial on embryo chromosome analysis. He discusses the ability to analyze every single chromosome in a cell that is taken from the embryo, and only transferring embryos that are chromosomally normal.
Learn how PGS and PGD solutions can produce accurate genomic information for optimized embryo selection and more informed decisions about reproductive options.
"RGH Counseling Guide Booklet Learn about the latest PGS and NIPT tool with this informative booklet highlighting app features and a quick start guide.<sup>┼</sup><br><br> <sup>┼</sup> This RGH Counseling Guide is intended to offer health care providers basic information on genetic counseling and is for general educational purposes only. The guide is not intended to be used to substitute for the exercise of the health care provider’s professional judgment in providing professional services."
Dr. Angie Beltsos on the advantages of PGS for IVF practices | Illumina Video
Join Angie Beltsos, MD, as she explores the latest advancements in fertility. Topics include minimizing risk of hyperstimulation, optimizing health of the transferred embryo, and improving the odds…
Dr. Angie Beltsos on the advantages of PGS for IVF practices | Illumina Video
Preimplantation Genetic Screening—delivering more happy beginnings | Illumina Video
Dr. Robert Anderson, Director of the Southern California Center for Reproductive Medicine and Medical Director for the Southern California Institute for Reproductive Sciences, discusses how preimplantation…
Preimplantation Genetic Screening—delivering more happy beginnings | Illumina Video
Vy and Kyle B: A preimplantation genetic screening (PGS) patient success story | Illumina Video
Childhood sweethearts, now husband and wife, Vy and Kyle share their personal in vitro fertilization success story. You ll hear how Illumina preimplantation genetic screening (PGS) helped them fulfill…
Vy and Kyle B: A preimplantation genetic screening (PGS) patient success story | Illumina Video
A Preimplantation Genetic Diagnosis Pioneer Takes a Look Back
Dr. Leeanda Wilton of Melbourne IVF codeveloped genomic methods that were key predecessors of technologies that are now contributing to successful IVF pregnancies.
Dr. Don Leigh and his team at Genea are harnessing the speed and accuracy of the VeriSeq PGS Solution on the MiSeq System to assess the genetic viability of embryos.
verifi Prenatal Test Healthcare Professional Brochure
Equipping the Next Generation of Embryologists | Illumina Video
Embryologists from all over the world gathered for the Global Embryology Summit, an exclusive event featuring hands-on instructor-led workshops designed by fellow embryologists to improve best practices…
verifi<sup>®</sup> Prenatal Test brochure for HCPs
The Illumina Difference
Key opinion leaders in the fields of preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) discuss how partnering with Illumina has positively impacted families around the world.
Simon Fishel describes how preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) enable selection of embryos free of chromosomal problems for transfer.
NGS improves IVF success with healthier embryo selection
BlueFuse Multi Software Demo
Innovative BlueFuse Multi Software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. The seamless, scalable software solution helps simplify embryo screening and streamline the clinician’s workflow.
Preimplantation genetic diagnosis can be used where there is a risk of severe genetic disorders being inherited from parents. Join Professor Alan Handyside and Alan Thornhill as they introduce the Illumina karyomapping solution.
A Rational Approach to IVF according to published literature
Dr. Jamie Grifo explains how PGS can be used to deliver fast, accurate information that can guide choices and change patients’ lives and reproductive futures.
A Rational Approach to IVF according to published literature
Simon Fishel Discusses Chromosome Screening
Simon Fishel, Managing Director of CARE Fertility, describes a clinical trial on embryo chromosome analysis. He discusses the ability to analyze every single chromosome in a cell that is taken from the embryo, and only transferring embryos that are chromosomally normal.
Talia & Dan H. | A Noninvasive Prenatal Screening Patient Success Story
Equipping the Next Generation of Embryologists | Illumina Video
Embryologists from all over the world gathered for the Global Embryology Summit, an exclusive event featuring hands-on instructor-led workshops designed by fellow embryologists to improve best practices…
Equipping the Next Generation of Embryologists | Illumina Video
Dr. Angie Beltsos on the advantages of PGS for IVF practices | Illumina Video
Join Angie Beltsos, MD, as she explores the latest advancements in fertility. Topics include minimizing risk of hyperstimulation, optimizing health of the transferred embryo, and improving the odds…
Dr. Angie Beltsos on the advantages of PGS for IVF practices | Illumina Video
Preimplantation Genetic Screening—delivering more happy beginnings | Illumina Video
Dr. Robert Anderson, Director of the Southern California Center for Reproductive Medicine and Medical Director for the Southern California Institute for Reproductive Sciences, discusses how preimplantation…
Preimplantation Genetic Screening—delivering more happy beginnings | Illumina Video
Vy and Kyle B: A preimplantation genetic screening (PGS) patient success story | Illumina Video
Childhood sweethearts, now husband and wife, Vy and Kyle share their personal in vitro fertilization success story. You ll hear how Illumina preimplantation genetic screening (PGS) helped them fulfill…
VeriSeq Preimplantation Genetic Screening (PGS) with BlueFuse | Illumina Video
Discover the NextSeq 550–flexible sequencing and array power
Learn how the NextSeq 550 is enhancing research in reproductive and genetic health and why it’s being rapidly adopted in genetic testing labs. Get a glimpse into the advantages of this integrated, cost-effective solution for diverse applications.
Array CGH Improves Pregnancy Rate for IVF Patients
Yang et al reported a 65% increase in pregnancy at 20 weeks, with a 69.1% pregnancy rate after 24sure selection of euploid embryos (n = 55) versus 41.7% after standard morphological selection of embryos (n = 48).
Learn about the 2011-2012 Society for Assisted Reproductive Technology (SART) data analysis of pregnancy outcomes in IVF cycles with and without PGS as reported to the Centers for Disease Control (CDC).
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Prenatal testing with the use of cfDNA has significantly lower false positive rates and higher positive predictive values for detection of trisomies 21 and 18 than standard screening.
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Continuing Medical Education (CME)
"Illumina is committed to supporting independent medical education for women's healthcare providers. Click above to participate in a free CME activity about ""The Role of Noninvasive Prenatal Screening in Optimizing Fetal Outcomes"". "
To learn more about the benefits of an expanded CF screen, read “Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.” by PR Sosnay, et al.
Learn how PGS and PGD solutions can produce accurate genomic information for optimized embryo selection and more informed decisions about reproductive options.
Clinical laboratory experience with noninvasive prenatal testing in twin gestations
A Preimplantation Genetic Diagnosis Pioneer Takes a Look Back
Dr. Leeanda Wilton of Melbourne IVF codeveloped genomic methods that were key predecessors of technologies that are now contributing to successful IVF pregnancies.
Dr. Don Leigh and his team at Genea are harnessing the speed and accuracy of the VeriSeq PGS Solution on the MiSeq System to assess the genetic viability of embryos.
Rapid Whole-Genome Sequencing in Neonatal Intensive Care Units
Whole-genome sequencing can potentially broaden and foreshorten differential diagnosis, resulting in fewer empirical treatments and faster progression to genetic and prognostic counseling.
Identifying Causal Variants of Cardiomyopathy: Dr Heidi Rehm
A Bright Future for PGS & PGD
Simon Fishel describes how the highly-accurate VeriSeq PGS Kit empowers clinicians with accurate chromosomal insights into the health of the embryo to optimize IVF success.
Learn about a randomized controlled trial comparing pregnancy rates following VeriSeq PGS versus standard morphology for elective single embryo transfer.